Mercy Medical Oncologist Dr. David Riseberg Discusses Hormone Therapy For Treating Breast Cancer

October 6, 2014
Medical Oncology at Mercy - Baltimore

Many people have survived breast cancer to tell their tales, and that survival can often be attributed to a long-term strategic plan that a doctor and patient have committed to, including using medication so the cancer doesn't come back.

When Monica Lovins and her oncologist, Mercy’s Dr. David Riseberg, Director of Breast Medical Oncology, discussed how they would fight her breast cancer, they had a plan of attack.

"Dr. Riseberg encouraged me to have chemotherapy first to shrink the tumors as much as possible. After that, we would do surgical interventions," Lovins said.

It was a lot for the Howard County mom to go through, but Lovins is a nurse practitioner, so she knew it wouldn't be easy.

Four years after her diagnosis, she said one thing is certain: "Once you've had an episode of breast cancer, you don't want to have a reoccurrence of breast cancer."

Dr. Riseberg doesn't want to see breast cancer come back, either, but he said often times it does. Tamoxifen is an option for patients to help prevent that reoccurrence.

"Years down the road, the original cancer might be gone, but there's a new cancer in another portion of the breast or the other breast that could develop, and this (drug) lowers it by half," Dr. Riseberg said.

A recent study showed that the longer a patient takes the estrogen-blocking medication, the better. Patients like Lovins may take it for 10 years.

"Part of cancer survivorship is really committing to the therapy from the beginning with a good plan, right straight through the five to 10 years after," Lovins said.

View Dr. Riseberg’s “Woman’s Doctor” interview with WBAL-TV11 regarding breast cancer, Tamoxifen and hormone treatment.


Dan Collins - Senior Director of Media Relations at Mercy Medical Center

Dan Collins, Senior Director of Media Relations

Email: dcollins@mdmercy.com Office: 410-332-9714 Cell: 410-375-7342

About Mercy

Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on FacebookTwitter, or call 1-800-MD-Mercy.

News and Events